These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 19664387

  • 1. [Effects of quercetin on the expression of VEGF-C and VEGFR-3 in human cancer MGC-803 cells].
    Yu ZJ, He LY, Chen Y, Wu MY, Zhao XH, Wang ZY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):678-80. PubMed ID: 19664387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR, Min K, Kim HS, Jung WW, Park YK.
    Pathol Res Pract; 2008 Aug; 204(8):575-82. PubMed ID: 18440723
    [Abstract] [Full Text] [Related]

  • 4. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
    Yano A, Fujii Y, Iwai A, Kawakami S, Kageyama Y, Kihara K.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6012-7. PubMed ID: 17062674
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ, Li HG, Xie DR, Zhang HZ, Shen XM, Zeng YJ, Zeng H.
    Ai Zheng; 2005 Sep 15; 24(9):1132-5. PubMed ID: 16159440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A.
    Br J Cancer; 2006 Jul 03; 95(1):75-9. PubMed ID: 16755294
    [Abstract] [Full Text] [Related]

  • 12. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
    Jennbacken K, Vallbo C, Wang W, Damber JE.
    Prostate; 2005 Oct 01; 65(2):110-6. PubMed ID: 15880525
    [Abstract] [Full Text] [Related]

  • 13. VEGFR-3, VEGF-C and VEGF-D mRNA quantification by RT-PCR in different human cell types.
    Leclers D, Durand K, Cook-Moreau J, Rabinovitch-Chable H, Sturtz FG, Rigaud M.
    Anticancer Res; 2006 Oct 01; 26(3A):1885-91. PubMed ID: 16827121
    [Abstract] [Full Text] [Related]

  • 14. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
    He XW, Liu T, Chen YX, Cheng DJ, Li XR, Xiao Y, Feng YL.
    Cancer Gene Ther; 2008 Mar 01; 15(3):193-202. PubMed ID: 18202713
    [Abstract] [Full Text] [Related]

  • 15. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
    Maekawa S, Iwasaki A, Shirakusa T, Enatsu S, Kawakami T, Kuroki M, Kuroki M.
    Anticancer Res; 2007 Mar 01; 27(6A):3735-41. PubMed ID: 17970036
    [Abstract] [Full Text] [Related]

  • 16. The role of the VEGF-C/VEGFR-3 axis in cancer progression.
    Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC, Kuo ML.
    Br J Cancer; 2007 Feb 26; 96(4):541-5. PubMed ID: 17164762
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N.
    Cancer; 2005 Oct 15; 104(8):1668-77. PubMed ID: 16116610
    [Abstract] [Full Text] [Related]

  • 18. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
    Yang J, Wu HF, Qian LX, Zhang W, Hua LX, Yu ML, Wang Z, Xu ZQ, Sui YG, Wang XR.
    Asian J Androl; 2006 Mar 15; 8(2):169-75. PubMed ID: 16491267
    [Abstract] [Full Text] [Related]

  • 19. VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression.
    Liu P, Zhou J, Zhu H, Xie L, Wang F, Liu B, Shen W, Ye W, Xiang B, Zhu X, Shi R, Zhang S.
    Cytokine; 2011 Jul 15; 55(1):8-17. PubMed ID: 21482472
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E, Alexandrou P, Mpakali A, Giannopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L.
    Eur J Surg Oncol; 2007 Apr 15; 33(3):294-300. PubMed ID: 17129704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.